MEGAN HADDY: Open Payments
NPI 1568144822 · YUBA CITY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$861 in 38 payments from 11 companies in 2025. Trend: 2023 $125 · 2024 $407 · 2025 $861
Food & beverage: $766Education: $94
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $261 |
| ABBVIE INC. | 8 | $162 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $108 |
| Lilly USA, LLC | 4 | $98 |
| Madrigal Pharmaceuticals | 2 | $68 |
| QOL Medical, LLC | 2 | $50 |
| Phathom Pharmaceuticals, Inc. | 3 | $37 |
| Braintree Laboratories, Inc. | 1 | $27 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $25 |
| PFIZER INC. | 1 | $14 |
Products named: TREMFYA, ENTYVIO, OMVOH, REZDIFFRA, RINVOQ, LINZESS, Sucraid, VOQUEZNA.
Industry payments across CA — which companies pay providers there.
